Tag - OBI

Developments

First patients recruited into Ondine’s Steriwave ICU pilot study

Ondine Biomedical (LON:OBI) announced the initiation of patient recruitment for an intensive care unit (ICU) pilot study at Royal Columbian Hospital (RCH) in New Westminster, British Columbia. The company states that...

March 20, 2025

Developments

Ondine receives TAYYABA HASAN IMPACT AWARD at IPA World Congress

Ondine Biomedical (LON:OBI) was awarded the TAYYABA HASAN IMPACT AWARD at the 18th World Congress of International Photodynamic Association (IPA) in Finland for demonstrating “exceptional perseverance and clinical...

July 17, 2023

Executive Moves

Ondine Biomedical names Simon Sinclair as CMO

Ondine Biomedical (LON:OBI) appointed Simon Sinclair, M.D., Ph.D., as chief medical officer, as the company prepares to start a U.S. Phase 3 trial of its nasal photodisinfection technology. Dr. Sinclair has more than 20...

June 1, 2023

Developments

Ondine presents effective photodisinfection treatment research against MRSA

Ondine Biomedical (LON:OBI) presented new research at the Infection Prevention Society Conference in Bournemouth, UK showing that its Steriwave photodisinfection technology is highly effective against clinical MRSA...

October 19, 2022

Tag - OBI

First patients recruited into Ondine’s Steriwave ICU pilot study

Ondine receives TAYYABA HASAN IMPACT AWARD at IPA World Congress

Ondine Biomedical names Simon Sinclair as CMO

Ondine presents effective photodisinfection treatment research against MRSA

Subscribe